81 medicines recommended for approval, including 27 new active substances

The European Medicines Agency (EMA) has published an overview of its key recommendations of 2016 in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines.

In 2016, EMA recommended 81 medicines for marketing authorisation, including 27 new active substances.

A selection of these recommendations can be found in the human medicines highlights document released today.

Posted on the EMA website on 17 January 2017